An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling

EMBO Journal

Volumn 27, Issue 22, 2008, Pages 2955-2965

  Ikushima, Hiroaki ^a   Komuro, Akiyoshi ^a   Isogaya, Kazunobu ^a   Shinozaki, Masahiko ^a   Hellman, Ulf ^b   Miyazawa, Keiji ^a   Miyazono, Kohei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

HHM; Olig1; Smad; Synexpression group; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HELIX LOOP HELIX PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR B; PROTEIN HHM; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OLIG1; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-SIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

GASTROPODA;

EID: 56549112482     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2008.218     Document Type: Article

References (36)

1. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111-2115
2. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor β in human disease. N Engl J Med 342: 1350-1358
3. Brena RM, Morrison C, Liyanarachchi S, Jarjoura D, Davuluri RV, Otterson GA, Reisman D, Glaros S, Rush LJ, Plass C (2007) Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. Plos Med 4: e108
4. Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J, Seoane J (2007) High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160
5. Cohen P (2002) Protein kinases - the major drug targets of the twenty-first century? Nat Rev Drug Discov 1: 309-315
6. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100
7. Derynck R, Zhang Y (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584
8. Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K (2007) TGF-β promotes survival of mammary carcinoma cells through induction of anti-apoptotic transcription factor DEC1. Cancer Res 67: 9694-9703
9. Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J Biol Chem 282: 20603-20611
10. Hellman U (2000) Sample preparation by SDS/PAGE and in-gel digestion. EXS 88: 43-54
11. Hwang SY, Oh B, Füchtbauer A, Füchtbauer EM, Johnson KR, Solter D, Knowles BB (1997) Maid: a maternally transcribed novel gene encoding a potential negative regulator of bHLH proteins in the mouse egg and zygote. Dev Dyn 209: 217-226
12. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J Biol Chem 266: 23048-23052
13. Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, ten Dijke P, Heldin CH, Ericsson J, Moustakas A (2003) Nuclear factor YY1 inhibits transforming growth factor β- and bone morphogenetic protein-induced cell differentiation. Mo Cell Biol 23: 4494-4510
14. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, Depinho RA, Anderson DJ, Stiles CD, Rowitch DH (2007) Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53: 503-517
15. Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH, Black PM (2001) Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA 98: 10851-10856
16. Ma W, Stafford LJ, Li D, Luo J, Li X, Ning G, Liu M (2007) GCIP/ CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis. J Cell Biochem 100: 1376-1386
17. Ma W, Xia X, Stafford LJ, Yu C, Wang F, LeSage G, Liu M (2006) Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis. Oncogene 25: 4207-4216
18. Massari ME, Murre C (2000) Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 20: 429-440
19. Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K (2003) SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells. Cancer Res 63: 7791-7798
20. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 7: 1191-1204
21. Nagata M, Goto K, Ehata S, Kobayashi N, Saitoh M, Miyoshi H, Imamura T, Miyazawa K, Miyazono K (2006) Nuclear and cytoplasmic c-Ski differently modulate cellular functions. Genes Cells 11: 1267-1280
22. Nishihara A, Hanai JI, Imamura T, Miyazono K, Kawabata M (1999) E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J Biol Chem 274: 28716-28723
23. Norton JD (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905
24. Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131-4142
25. Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700
26. Sonnenberg-Riethmacher E, Wüstefeld T, Miehe M, Trautwein C, Riethmacher D (2007) Maid (GCIP) is involved in cell cycle control of hepatocytes. Hepatology 45: 404-411
27. Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K (2004) c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 23: 5068-5076
28. Takami T, Terai S, Yokoyama Y, Tanimoto H, Tajima K, Uchida K, Yamasaki T, Sakaida I, Nishina H, Thorgeirsson SS, Okita K (2005) Human homologue of maid is a useful marker protein in hepatocarcinogenesis. Gastroenterology 128: 1369-1380
29. Terai S, Aoki H, Ashida K, Thorgeirsson SS (2000) Human homologue of maid: a dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression. Hepatology 32: 357-366
30. Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014
31. Xia C, Bao Z, Tabassam F, Ma W, Qiu M, Hua S, Liu M (2000) GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity. J Biol Chem 275: 20942-20948
32. Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR (2005) Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25: 1354-1365
33. Yao Y, Doki Y, Jiang W, Imoto M, Venkatraj VS, Warburton D, Santella RM, Lu B, Yan L, Sun XH, Su T, Luo J, Weinstein IB (2000) Cloning and characterization of DIP1, a novel protein that is related to the Id family of proteins. Exp Cell Res 257: 22-32
34. Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGF-β signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3: 1011-1022
35. Zavadil J, Böttinger EP (2005) TGF-β and epithelial-to- mesenchymal transitions. Oncogene 24: 5764-5774
36. Zhou Q, Wang S, Anderson DJ (2000) Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25: 331-343